Arizona Attorney General Moves Against Purdue Pharma

Richard Sackler, Who Co-Owns Oxycontin-Maker Purdue Pharma, Gets Patent for New Buprenorphine That Would Treat Opioid Addiction

Colorado's Attorney General Sues Purdue Pharma

Richard Sackler and his billionaire family, which owns the Oxy-making Purdue Pharma, also runs Rhodes Pharma in Rhode Island - one of the biggest producers of generic opioids, which had never before been linked to the family, the Financial Times revealed.

"The basis of our lawsuit is this: Purdue Pharma lied, they misrepresented, they fabricated, they deceived, and they spread falsehoods, and they made billions off of it and they created a path of destruction that the state of Vermont is still reeling from", Donovan said.

Josephson says: "We share the state's concern about the opioid crisis". More than 63,000 people in the USA died from drug overdoses in 2016, of which 66 percent were related to opioid use.

The patent application says the new drug would help ease crime caused by addicts, but doesn't mention the thousand-plus lawsuits filed against Purdue Pharma for allegedly spurring the opioid epidemic. The Washington Post highlights a statement by Luke Nasta, director of NY addiction treatment center Camelot. Then earlier this year, the Wall Street Journal reported that Purdue planned to stop promoting the drug. He told the newspaper that the Sackler family "shouldn't be allowed to peddle any more synthetic opiates - and that includes opioid substitutes".

Unofficial iPhone Xr video showcases Apple's most intriguing phone of 2018
Likewise, if you own an Apple TV you can also tune in by using the Apple events app which comes pre-installed on the device. PT , the world is not only expecting Apple to reveal three new iPhones , but specifically the iPhone XS*.

"It's reprehensible what Purdue Pharma has done to our public health..." The drug is an altered form of buprenorphine, better known as Suboxone, which is a mild form of an opiate drug that helps curb cravings and can be offered as a temporary substitute for people addicted to heroin or other opioid drugs. The best-selling version of buprenorphine, Suboxone, made $877 million in USA sales for the British pharmaceutical company Indivior.

If Suboxone's success is any predictor, it is likely that Purdue Pharma will likely profit largely from its newly patented treatment drug.

Wilson also previously told VTDigger that Purdue needs to be "part of the solution" to cure the opioid crisis and the company is "supporting candidates who are taking prevention, treatment and enforcement seriously".

Latest News